The DOI matches its Crossref record; 207 of the 207 references it cites were found in a registry or an index.
Imaging Synaptic Neurotransmission with in Vivo Binding Competition Techniques: A Critical Review
Open accessAbstract
Several groups have provided evidence that positron emission tomography (PET) and single-photon emission computed tomography (SPECT) neuroreceptor imaging techniques might be applied to measure acute fluctuations in dopamine (DA) synaptic concentration in the living human brain. Competition between DA and radioligands for binding to D2 receptor is the principle underlying this approach. This new application of neuroreceptor imaging provides a dynamic measurement of neurotransmission that is likely to be informative to our understanding of neuropsychiatric conditions. This article reviews and discusses the body of data supporting the feasibility and potential of this imaging paradigm. Endogenous competition studies performed in rodents, nonhuman primates, and humans are first summarized. After this overview, the validity of the model underlying the interpretation of these imaging data is critically assessed. The current reference model is defined as the occupancy model, since changes in radiotracer binding potential (BP) are assumed to be directly caused by changes in occupancy of D2 receptors by DA. Experimental data supporting this model are presented. The evidence that manipulation of DA synaptic levels induces change in the BP of several D2 radiotracers (catecholamines and benzamides) is unequivocal. The fact that these changes in BP are mediated by changes in DA synaptic concentration is well documented. The relationship between the magnitude of BP changes measured with PET or SPECT and the magnitude of changes in DA concentration measured by microdialysis supports the use of these noninvasive techniques to measure changes in neurotransmission. On the other hand, several observations remain unexplained. First, the amphetamine-induced changes in the BP of D2 receptor antagonists [123I]IBZM and [11C]raclopride last longer than amphetamine-induced changes in DA extracellular concentration. Second, nonbenzamide D2 receptor antagonists, such as spiperone and pimozide, are not affected by changes in DA release, or are affected in a direction opposite to that predicted by the occupancy model. Similar observations are reported with D1 radiotracers. These results suggest that the changes in BP following changes in DA concentration might not be fully accounted by a simple occupancy model. Specifically, the data are reviewed supporting that agonist-mediated receptor internalization might play an important role in characterizing receptor-ligand interactions. Finally, it is proposed that a better understanding of the mechanism underlying the effects observed with benzamides is essential to develop this imaging technique to other receptor systems.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Consequently, we were not able to assess whether dynamics such as receptor internalization (Laruelle, 2000) or changes in the affinity of D2/D3 receptors for dopamine and/or fallypride were implicated (Laruelle, 2000; Gjedde et al., 2005).”
From A positron emission tomography study of nigro-striatal dopaminergic mechanisms underlying attention: implications for ADHD and its treatment (2013) · cites this paper as Laruelle, 2000
Citations
Cites
Yung-Chi, C., & Prusoff, W. H. (1973) · Biochemical Pharmacology · doi:10.1016/0006-2952(73)90196-2 · Cited by 12,922
Graphical Evaluation of Blood-to-Brain Transfer Constants from Multiple-Time Uptake Data
Patlak, C. S., Blasberg, R. G., & Fenstermacher, J. D. (1983) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.1983.1 · Cited by 3,565
Grace, A. A. (1991) · Neuroscience · doi:10.1016/0306-4522(91)90196-u · Cited by 1,831
Logan, J., Fowler, J. S., Volkow, N. D., Wolf, A. P., Dewey, S. L., Schlyer, D. J., MacGregor, R. R., HITZEMANN, R. J., Bendriem, B., Gatley, S. J., et al. (1990) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.1990.127 · Cited by 1,481
Farde, L. (1992) · Archives of General Psychiatry · doi:10.1001/archpsyc.1992.01820070032005 · Cited by 1,420
Laruelle, M., Abi-Dargham, A., van Dyck, C. H., Gil, R., D'Souza, C. D., Erdos, J., McCance, E., Rosenblatt, W., Fingado, C., Zoghbi, S. S., et al. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.17.9235 · Cited by 1,291
Self-citationEvidence for striatal dopamine release during a video game
Koepp, M. J., Gunn, R. N., Lawrence, A. D., Cunningham, V. J., Dagher, A., Jones, T., Brooks, D. J., Bench, C. J., & Grasby, P. M. (1998) · Nature · doi:10.1038/30498 · Cited by 1,279
Breier, A., Su, T.-P., Saunders, R., Carson, R. E., Kolachana, B. S., de Bartolomeis, A., Weinberger, D. R., Weisenfeld, N., Malhotra, A. K., Eckelman, W. C., et al. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.6.2569 · Cited by 1,154
Positron Emission Tomography Reveals Elevated D 2 Dopamine Receptors in Drug-Naive Schizophrenics
Wong, D. F., Wagner, H. N., Tune, L. E., Dannals, R. F., Pearlson, G. D., Links, J. M., Tamminga, C. A., Broussolle, E., Ravert, H. T., Wilson, A. A., et al. (1986) · Science · doi:10.1126/science.2878495 · Cited by 928
Increased striatal dopamine transmission in schizophrenia: confirmation in a second cohort.
Abi-Dargham, A., Gil, R. B., Krystal, J., Baldwin, R., Seibyl, J., Bowers, M., van Dyck, C., Charney, D., Innis, R., & Laruelle, M. (1998) · American Journal of Psychiatry · doi:10.1176/ajp.155.6.761 · Cited by 860
Self-citation
Research works printed but not linked: 35
- Abi-Dargham A, 1995, J Nucl Med, 36, 167
- Ann X, 1998, Soc Neurosci Abstr, 24, 857
- Barton AC, 1991, Mol Pharmacol, 39, 650
- Booij J, 1997, Eur J Nucl Med, 24, 674
- Chatterjee TK, 1988, Mol Pharmacol, 33, 402
- Ding YS, 1998, J Nucl Med, 39, 12P
- Feger J, 1994, Cell Mol Biol (Noisy-le-grand), 40, 1039
- Fischer JF, 1979, J Pharmacol Exp Ther, 208, 203
- Florin SM, 1995, J Pharmacol Exp Ther, 274, 231
- Grady EF, 1997, Am J Physiol, 273, G586
- Greenwald E, 1998, J Nucl Med, 39, 236P
- Guo NN, 1999, Soc Neurosci Abstr, 25, 953
- Itokawa M, 1996, Mol Pharmacol, 49, 560
- Kessler RM, 1991, J Nucl Med, 32, 1593
- Kim SE, 1998, J Nucl Med, 39, 54P
- Kung HF, 1988, Nucl Med Biol, 15, 195
- Kung M-P, 1990, J Nucl Med, 31, 648
- Laruelle M, 1998, Soc Neurosci Abstr, 24, 22
- Laruelle M, 1995, J Nucl Med, 36, 1182
- Laruelle M, 1994, J Nucl Med, 35, 743
- Malison RT, 1999, J Nucl Med, 40, 110P
- Neve KA, 1991, Mol Pharmacol, 39, 570
- Ng GYK, 1996, Soc Neurosci Abstr, 22, 825
- Parker EM, 1986, J Pharmacol Exp Ther, 237, 179
- Pifl C, 1995, Mol Pharmacol, 47, 368
- Raiteri M, 1979, J Pharmacol Exp Ther, 208, 195
- Ross SB, 1989, Naunyn Schmiedebergs Arch Pharmacol, 340, 6
- Ross SB, 1989, Naunyn Schmiedebergs Arch Pharmacol, 340, 13
- Saelens JK, 1980, Arch Int Pharmacodyn Ther, 246, 98
- Schlaepfer TE, 1997, Arch J Psychiatry, 154, 1209
- Seeman P, 1993, Receptor Tables: Drug Dissociation Constants for Neuroreceptors and Transporters, 2
- Seeman P, 1985, Mol Pharmacol, 28, 391
- Uretsky NJ, 1977, J Pharmacol Exp Ther, 202, 565
- Villemagne VL, 1988, J Nucl Med, 39, 55P
- Wang GJ, 1999, J Nucl Med, 40, 1285
Cited by
Sorted by citations
The Dopamine Hypothesis of Schizophrenia: Version III--The Final Common Pathway
Howes, O. D., & Kapur, S. (2009) · Schizophrenia Bulletin · doi:10.1093/schbul/sbp006 · Cited by 2,693
Increased baseline occupancy of D 2 receptors by dopamine in schizophrenia
Abi-Dargham, A., Rodenhiser, J., Printz, D., Zea-Ponce, Y., Gil, R., Kegeles, L. S., Weiss, R., Cooper, T. B., Mann, J. J., Van Heertum, R. L., et al. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.14.8104 · Cited by 1,020
Self-citationDopamine as a Prolactin (PRL) Inhibitor
Ben-Jonathan, N., & Hnasko, R. (2001) · Endocrine Reviews · doi:10.1210/edrv.22.6.0451 · Cited by 983
Prefrontal Dopamine D1Receptors and Working Memory in Schizophrenia
Abi-Dargham, A., Mawlawi, O., Lombardo, I., Gil, R., Martinez, D., Huang, Y., Hwang, D.-R., Keilp, J., Kochan, L., Van Heertum, R., et al. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-09-03708.2002 · Cited by 724
Self-citationAmphetamine-induced dopamine release in human ventral striatum correlates with euphoria
Drevets, W. C., Gautier, C., Price, J. C., Kupfer, D. J., Kinahan, P. E., Grace, A. A., Price, J. L., & Mathis, C. A. (2001) · Biological Psychiatry · doi:10.1016/s0006-3223(00)01038-6 · Cited by 706
Pruessner, J. C., Champagne, F., Meaney, M. J., & Dagher, A. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.3422-03.2004 · Cited by 709
Social dominance in monkeys: dopamine D2 receptors and cocaine self-administration
Morgan, D., Grant, K. A., Gage, H. D., Mach, R. H., Kaplan, J. R., Prioleau, O., Nader, S. H., Buchheimer, N., Ehrenkaufer, R. L., & Nader, M. A. (2002) · Nature Neuroscience · doi:10.1038/nn798 · Cited by 674
Small, D. M., Jones-Gotman, M., & Dagher, A. (2003) · NeuroImage · doi:10.1016/s1053-8119(03)00253-2 · Cited by 632
Alcohol promotes dopamine release in the human nucleus accumbens
Boileau, I., Assaad, J., Pihl, R. O., Benkelfat, C., Leyton, M., Diksic, M., Tremblay, R. E., & Dagher, A. (2003) · Synapse · doi:10.1002/syn.10226 · Cited by 591
Increased Synaptic Dopamine Function in Associative Regions of the Striatum in Schizophrenia
Kegeles, L. S., Abi-Dargham, A., Frankle, W. G., Gil, R., Cooper, T. B., Slifstein, M., Hwang, D.-R., Huang, Y., Haber, S. N., & Laruelle, M. (2010) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2010.10 · Cited by 565
Self-citationMartinez, D., Slifstein, M., Broft, A., Mawlawi, O., Hwang, D.-R., Huang, Y., Cooper, T., Kegeles, L., Zarahn, E., Abi-Dargham, A., et al. (2003) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/01.wcb.0000048520.34839.1a · Cited by 569
Self-citationThe Runner's High: Opioidergic Mechanisms in the Human Brain
Boecker, H., Sprenger, T., Spilker, M. E., Henriksen, G., Koppenhoefer, M., Wagner, K. J., Valet, M., Berthele, A., & Tolle, T. R. (2008) · Cerebral Cortex · doi:10.1093/cercor/bhn013 · Cited by 527
Mawlawi, O., Martinez, D., Slifstein, M., Broft, A., Chatterjee, R., Hwang, D.-R., Huang, Y., Simpson, N., Ngo, K., Van Heertum, R., et al. (2001) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-200109000-00002 · Cited by 525
Self-citationLeyton, M. (2002) · Neuropsychopharmacology · doi:10.1016/s0893-133x(02)00366-4 · Cited by 476
Volkow, N. D., Wang, G., Fowler, J. S., Logan, J., Jayne, M., Franceschi, D., Wong, C., Gatley, S. J., Gifford, A. N., Ding, Y., et al. (2002) · Synapse · doi:10.1002/syn.10075 · Cited by 452
Bäckman, L., Lindenberger, U., Li, S.-C., & Nyberg, L. (2010) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2009.12.008 · Cited by 414
Glutamate, Dopamine, and Schizophrenia: From Pathophysiology to Treatment
LARUELLE, M., KEGELES, L. S., & ABI‐DARGHAM, A. (2003) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1300.063 · Cited by 437
Self-citationAdenosine receptors and brain diseases: neuroprotection and neurodegeneration
Gomes, C. V., Kaster, M. P., Tomé, A. R., Agostinho, P. M., & Cunha, R. A. (2011) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2010.12.001 · Cited by 419
The reticular-activating hypofrontality (RAH) model of acute exercise
Dietrich, A., & Audiffren, M. (2011) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2011.02.001 · Cited by 365
Neurobiology of Dopamine in Schizophrenia
Guillin, O., Abi‐Dargham, A., & Laruelle, M. (2007) · International Review of Neurobiology · doi:10.1016/s0074-7742(06)78001-1 · Cited by 365
Self-citationμ-Opioid Receptor-Mediated Antinociceptive Responses Differ in Men and Women
Zubieta, J.-K., Smith, Y. R., Bueller, J. A., Xu, Y., Kilbourn, M. R., Jewett, D. M., Meyer, C. R., Koeppe, R. A., & Stohler, C. S. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-12-05100.2002 · Cited by 363
Martinez, D., Narendran, R., Foltin, R. W., Slifstein, M., Hwang, D.-R., Broft, A., Huang, Y., Cooper, T. B., Fischman, M. W., Kleber, H. D., et al. (2007) · American Journal of Psychiatry · doi:10.1176/ajp.2007.164.4.622 · Cited by 351
Self-citationVolkow, N. D., Wang, G., Fowler, J. S., Logan, J., Franceschi, D., Maynard, L., Ding, Y., Gatley, S. J., Gifford, A., Zhu, W., et al. (2002) · Synapse · doi:10.1002/syn.10038 · Cited by 321
Boileau, I., Dagher, A., Leyton, M., Gunn, R. N., Baker, G. B., Diksic, M., & Benkelfat, C. (2006) · Archives of General Psychiatry · doi:10.1001/archpsyc.63.12.1386 · Cited by 305
Heinz, A., Siessmeier, T., Wrase, J., Buchholz, H. G., Gründer, G., Kumakura, Y., Cumming, P., Schreckenberger, M., Smolka, M. N., Rösch, F., et al. (2005) · American Journal of Psychiatry · doi:10.1176/appi.ajp.162.8.1515 · Cited by 285
Increased stress-induced dopamine release in psychosis
Mizrahi, R., Addington, J., Rusjan, P. M., Suridjan, I., Ng, A., Boileau, I., Pruessner, J. C., Remington, G., Houle, S., & Wilson, A. A. (2012) · Biological Psychiatry · doi:10.1016/j.biopsych.2011.10.009 · Cited by 277
Elevated Intrasynaptic Dopamine Release in Tourette’s Syndrome Measured by PET
Singer, H. S., Szymanski, S., Giuliano, J., Yokoi, F., Dogan, A. S., Brasic, J. R., Zhou, Y., Grace, A. A., & Wong, D. F. (2002) · American Journal of Psychiatry · doi:10.1176/appi.ajp.159.8.1329 · Cited by 259
Dopamine Transmission in the Human Striatum during Monetary Reward Tasks
Zald, D. H., Boileau, I., El-Dearedy, W., Gunn, R., McGlone, F., Dichter, G. S., & Dagher, A. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.4643-03.2004 · Cited by 238
Dopamine hypothesis of schizophrenia: Making sense of it all
Toda, M., & Abi-Dargham, A. (2007) · Current Psychiatry Reports · doi:10.1007/s11920-007-0041-7 · Cited by 235
Brain dopamine is associated with eating behaviors in humans
Volkow, N. D., Wang, G., Maynard, L., Jayne, M., Fowler, J. S., Zhu, W., Logan, J., Gatley, S. J., Ding, Y., Wong, C., et al. (2003) · International Journal of Eating Disorders · doi:10.1002/eat.10118 · Cited by 235
All Roads to Schizophrenia Lead to Dopamine Supersensitivity and Elevated Dopamine D2High Receptors
Seeman, P. (2011) · CNS Neuroscience & Therapeutics · doi:10.1111/j.1755-5949.2010.00162.x · Cited by 228
Perani, D., Garibotto, V., Gorini, A., Moresco, R. M., Henin, M., Panzacchi, A., Matarrese, M., Carpinelli, A., Bellodi, L., & Fazio, F. (2008) · NeuroImage · doi:10.1016/j.neuroimage.2008.04.233 · Cited by 219
Boileau, I., Dagher, A., Leyton, M., Welfeld, K., Booij, L., Diksic, M., & Benkelfat, C. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.4370-06.2007 · Cited by 222
Abi-Dargham, A., van de Giessen, E., Slifstein, M., Kegeles, L. S., & Laruelle, M. (2009) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.12.007 · Cited by 213
Martinez, D., Carpenter, K. M., Liu, F., Slifstein, M., Broft, A., Friedman, A. C., Kumar, D., Van Heertum, R., Kleber, H. D., & Nunes, E. (2011) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2010.10050748 · Cited by 212
Hirvonen, M. M., Laakso, A., Någren, K., Rinne, J. O., Pohjalainen, T., & Hietala, J. (2009) · Synapse · doi:10.1002/syn.20672 · Cited by 176
Imaging addiction: D2 receptors and dopamine signaling in the striatum as biomarkers for impulsivity
Trifilieff, P., & Martinez, D. (2014) · Neuropharmacology · doi:10.1016/j.neuropharm.2013.06.031 · Cited by 171
Striatal ups and downs: Their roles in vulnerability to addictions in humans
Leyton, M., & Vezina, P. (2013) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2013.01.018 · Cited by 165
Meyer, J. H., McNeely, H. E., Sagrati, S., Boovariwala, A., Martin, K., Verhoeff, N. P. L. G., Wilson, A. A., & Houle, S. (2006) · American Journal of Psychiatry · doi:10.1176/ajp.2006.163.9.1594 · Cited by 160
Amphetamine-induced displacement of [18F] fallypride in striatum and extrastriatal regions in humans
Riccardi, P., Li, R., Ansari, M. S., Zald, D., Park, S., Dawant, B., Anderson, S., Doop, M., Woodward, N., Schoenberg, E., et al. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300916 · Cited by 134
Dopamine D2 receptor availability and amphetamine-induced dopamine release in unipolar depression
Parsey, R. V., Oquendo, M. A., Zea-Ponce, Y., Rodenhiser, J., Kegeles, L. S., Pratap, M., Cooper, T. B., Van Heertum, R., Mann, J. J., & Laruelle, M. (2001) · Biological Psychiatry · doi:10.1016/s0006-3223(01)01089-7 · Cited by 133
Self-citationRosa-Neto, P., Lou, H. C., Cumming, P., Pryds, O., Karrebaek, H., Lunding, J., & Gjedde, A. (2005) · NeuroImage · doi:10.1016/j.neuroimage.2004.11.031 · Cited by 135
Thanos, P. K., Michaelides, M., Piyis, Y. K., Wang, G., & Volkow, N. D. (2008) · Synapse · doi:10.1002/syn.20468 · Cited by 135
Acute prefrontal rTMS increases striatal dopamine to a similar degree as D-amphetamine
Pogarell, O., Koch, W., Pöpperl, G., Tatsch, K., Jakob, F., Mulert, C., Grossheinrich, N., Rupprecht, R., Möller, H.-J., Hegerl, U., et al. (2007) · Psychiatry Research Neuroimaging · doi:10.1016/j.pscychresns.2007.05.002 · Cited by 133
Abi-Dargham, A., Kegeles, L. S., Zea-Ponce, Y., Mawlawi, O., Martinez, D., Mitropoulou, V., O'Flynn, K., Koenigsberg, H. W., Van Heertum, R., Cooper, T., et al. (2004) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.01.018 · Cited by 128
Self-citationConditioned and sensitized responses to stimulant drugs in humans
Leyton, M. (2007) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2007.08.027 · Cited by 127
Motor and Nonmotor Complications of Levodopa: Phenomenology, Risk Factors, and Imaging Features
Ray Chaudhuri, K., Poewe, W., & Brooks, D. (2018) · Movement Disorders · doi:10.1002/mds.27386 · Cited by 121
del Campo, N., Fryer, T. D., Hong, Y. T., Smith, R., Brichard, L., Acosta-Cabronero, J., Chamberlain, S. R., Tait, R., Izquierdo, D., Regenthal, R., et al. (2013) · Brain · doi:10.1093/brain/awt263 · Cited by 113
An integrative framework for perceptual disturbances in psychosis
Horga, G., & Abi-Dargham, A. (2019) · Nature Reviews Neuroscience · doi:10.1038/s41583-019-0234-1 · Cited by 103
Seneca, N., Finnema, S. J., Farde, L., Gulyás, B., Wikström, H. V., Halldin, C., & Innis, R. B. (2006) · Synapse · doi:10.1002/syn.20238 · Cited by 110
Zijlstra, F., Booij, J., van den Brink, W., & Franken, I. H. A. (2008) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2007.11.002 · Cited by 109
Willeit, M., Ginovart, N., Graff, A., Rusjan, P., Vitcu, I., Houle, S., Seeman, P., Wilson, A. A., & Kapur, S. (2008) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301400 · Cited by 107
Impulsivity and chronic stress are associated with amphetamine-induced striatal dopamine release
Oswald, L. M., Wong, D. F., Zhou, Y., Kumar, A., Brasic, J., Alexander, M., Ye, W., Kuwabara, H., Hilton, J., & Wand, G. S. (2007) · NeuroImage · doi:10.1016/j.neuroimage.2007.01.055 · Cited by 108
Cropley, V. L., Innis, R. B., Nathan, P. J., Brown, A. K., Sangare, J. L., Lerner, A., Ryu, Y. H., Sprague, K. E., Pike, V. W., & Fujita, M. (2008) · Synapse · doi:10.1002/syn.20506 · Cited by 104
Mizrahi, R., Kenk, M., Suridjan, I., Boileau, I., George, T. P., McKenzie, K., Wilson, A. A., Houle, S., & Rusjan, P. (2014) · Neuropsychopharmacology · doi:10.1038/npp.2013.347 · Cited by 101
Thanos, P. K., Michaelides, M., Benveniste, H., Wang, G. J., & Volkow, N. D. (2007) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2007.05.020 · Cited by 100
Sun, W., Ginovart, N., Ko, F., Seeman, P., & Kapur, S. (2003) · Molecular Pharmacology · doi:10.1124/mol.63.2.456 · Cited by 99
Increased striatal dopamine (D2/D3) receptor availability and delusions in Alzheimer disease
Reeves, S., Brown, R., Howard, R., & Grasby, P. (2009) · Neurology · doi:10.1212/01.wnl.0000341932.21961.f3 · Cited by 98
Skinbjerg, M., Liow, J.-S., Seneca, N., Hong, J., Lu, S., Thorsell, A., Heilig, M., Pike, V. W., Halldin, C., Sibley, D. R., et al. (2010) · NeuroImage · doi:10.1016/j.neuroimage.2010.01.055 · Cited by 86
STEEVES, T., & FOX, S. (2008) · Progress in Brain Research · doi:10.1016/s0079-6123(08)00924-2 · Cited by 79
Striepens, N., Matusch, A., Kendrick, K. M., Mihov, Y., Elmenhorst, D., Becker, B., Lang, M., Coenen, H. H., Maier, W., Hurlemann, R., et al. (2014) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2013.09.026 · Cited by 71
Fluvoxamine Treatment and D2 Receptors: a Pet Study on OCD Drug-Naïve Patients
Moresco, R. M., Pietra, L., Henin, M., Panzacchi, A., Locatelli, M., Bonaldi, L., Carpinelli, A., Gobbo, C., Bellodi, L., Perani, D., et al. (2007) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301199 · Cited by 70
Rao, N., Northoff, G., Tagore, A., Rusjan, P., Kenk, M., Wilson, A., Houle, S., Strafella, A., Remington, G., & Mizrahi, R. (2019) · Schizophrenia Bulletin · doi:10.1093/schbul/sby076 · Cited by 67
Oral D‐amphetamine causes prolonged displacement of [11C]raclopride as measured by PET
Cárdenas, L., Houle, S., Kapur, S., & Busto, U. E. (2004) · Synapse · doi:10.1002/syn.10282 · Cited by 63
Beveridge, T. J. R., Smith, H. R., Nader, M. A., & Porrino, L. J. (2009) · Neuropsychopharmacology · doi:10.1038/npp.2008.135 · Cited by 64
Larisch, R., Sitte, W., Antke, C., Nikolaus, S., Franz, M., Tress, W., & M??ller, H.-W. (2006) · Nuclear Medicine Communications · doi:10.1097/00006231-200603000-00010 · Cited by 58
NETO, P. R., LOU, H., CUMMING, P., PRYDS, O., & GJEDDE, A. (2002) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2002.tb04184.x · Cited by 54
Amphetamine-induced dopamine release and neurocognitive function in treatment-naive adults with ADHD
Cherkasova, M. V., Faridi, N., Casey, K. F., O'Driscoll, G. A., Hechtman, L., Joober, R., Baker, G. B., Palmer, J., Dagher, A., Leyton, M., et al. (2014) · Neuropsychopharmacology · doi:10.1038/npp.2013.349 · Cited by 49
Gjedde, A., Wong, D. F., Rosa-Neto, P., & Cumming, P. (2005) · International review of neurobiology · doi:10.1016/s0074-7742(05)63001-2 · Cited by 50
Addiction theory matters—Why there is no dependence on caffeine or antidepressant medication
Heinz, A., Daedelow, L. S., Wackerhagen, C., & Di Chiara, G. (2020) · Addiction Biology · doi:10.1111/adb.12735 · Cited by 45
Bartelle, B. B., Barandov, A., & Jasanoff, A. (2016) · The Journal of Neuroscience · doi:10.1523/jneurosci.4050-15.2016 · Cited by 45
Jørgensen, L. M., Weikop, P., Villadsen, J., Visnapuu, T., Ettrup, A., Hansen, H. D., Baandrup, A. O., Andersen, F. L., Bjarkam, C. R., Thomsen, C., et al. (2017) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x16629483 · Cited by 44
van Berckel, B. N. M., Kegeles, L. S., Waterhouse, R., Guo, N., Hwang, D.-R., Huang, Y., Narendran, R., Van Heertum, R., & Laruelle, M. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300902 · Cited by 43
Self-citationDopamine release in nucleus accumbens during rewarded task switching measured by [¹¹C]raclopride
Jonasson, L. S., Axelsson, J., Riklund, K., Braver, T. S., Ögren, M., Bäckman, L., & Nyberg, L. (2014) · NeuroImage · doi:10.1016/j.neuroimage.2014.05.047 · Cited by 42
Takano, H. (2018) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2018.00228 · Cited by 34
Jedema, H. P., Narendran, R., & Bradberry, C. W. (2014) · Journal of Neurochemistry · doi:10.1111/jnc.12743 · Cited by 30
Lind, N. M., Gjedde, A., Moustgaard, A., Olsen, A. K., Jensen, S. B., Jakobsen, S., Arnfred, S. M., Hansen, A. K., Hemmingsen, R. P., & Cumming, P. (2005) · Behavioural Brain Research · doi:10.1016/j.bbr.2005.06.008 · Cited by 30
Mapping the amphetamine-evoked dopamine release in the brain of the Gottingen minipig
Lind, N. M., Olsen, A. K., Moustgaard, A., Jensen, S. B., Jakobsen, S., Hansen, A. K., Arnfred, S. M., Hemmingsen, R. P., Gjedde, A., & Cumming, P. (2005) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2004.08.007 · Cited by 28
Molecular Neurobiology of Depression: PET Findings on the Elusive Correlation with Symptom Severity
Smith, D. F., & Jakobsen, S. (2013) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2013.00008 · Cited by 25
Fujita, M., Al‐Tikriti, M. S., Tamagnan, G., Zoghbi, S. S., Bozkurt, A., Baldwin, R. M., & Innis, R. B. (2003) · Synapse · doi:10.1002/syn.10194 · Cited by 24
Udo de Haes, J. I., Kortekaas, R., Van Waarde, A., Maguire, R. P., Pruim, J., & den Boer, J. A. (2005) · Psychopharmacology · doi:10.1007/s00213-005-0193-2 · Cited by 18
Amphetamine Decreases 2C-Adrenoceptor Binding of [11C]ORM-13070: A PET Study in the Primate Brain
Finnema, S. J., Hughes, Z. A., Haaparanta-Solin, M., Stepanov, V., Nakao, R., Varnas, K., Varrone, A., Arponen, E., Marjamaki, P., Pohjanoksa, K., et al. (2015) · International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyu081 · Cited by 17
“PET measurements, combined with amphetamine administration, have previously been used to investigate changes in synaptic DA concentrations in humans (Laruelle, 2000).”
MethodMinuzzi, L., & Cumming, P. (2010) · Neurochemistry International · doi:10.1016/j.neuint.2010.01.010 · Cited by 15
Maternal dopamine encodes affective signals of human infants
Zeevi, L., Irani, M., Catana, C., Feldman Barrett, L., & Atzil, S. (2022) · Social Cognitive and Affective Neuroscience · doi:10.1093/scan/nsab116 · Cited by 12
In vivo PET Imaging of [11C]CIMBI-5, a 5-HT2AR Agonist Radiotracer in Nonhuman Primates
Prabhakaran, J., DeLorenzo, C., Zanderigo, F., Knudsen, G. M., Gilling, N., Pratap, M., Jorgensen, M. J., Daunais, J., Kaplan, J. R., Parsey, R. V., et al. (2019) · Journal of Pharmacy & Pharmaceutical Sciences · doi:10.18433/jpps30329 · Cited by 7
Metadata
- Authors
- Laruelle, M.
- Affiliations
- New York State Psychiatric Institute (US)
- Corresponding author
- Laruelle, Marc
- Venue
- Journal of Cerebral Blood Flow & Metabolism
- Publisher
- SAGE Publications
- Published
- 2000-03
- Volume
- 20
- Issue
- 3
- Pages
- 423-451
- ISSN
- 0271-678X (ISSN-L)
- 1559-7016
- OpenAlex
- W2054230322
- Cited by
- 944
- References
- 207
- Citations by year
- 2026: 6 · 2025: 8 · 2024: 8 · 2023: 10 · 2022: 15 · 2021: 26 · 2020: 18 · 2019: 28 · 2018: 26 · 2017: 31 · 2016: 31 · 2015: 36 · 2014: 54 · 2013: 47 · 2012: 36
- FWCI
- 4.78
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Cerebral Blood Flow & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute of Mental Health (K02MH01603-01, K02MH001603)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Medical Imaging Techniques and Applications
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Keywords
- dopamine D2 receptor, competitive binding, occupancy models, dopamine release, amphetamine, benzamide, receptor internalization, dopamine D1 receptor, microdialysis, SPECT
- MeSH terms
- Animals, Binding, Competitive, Brain, Dopamine, Humans, Ligands, Models, Neurological, Synaptic Transmission, Receptors, Dopamine, Tomography, Emission-Computed, Tomography, Emission-Computed, Single-Photon
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review